Physician

Jack Francis Quinlan, M.D.

According to 2025 Medicare claims, Jack Quinlan, M.D. (NPI: 1942460514) practices cardiology in the Vineland, NJ market, with the plurality of this provider's patient population coming from Cumberland, NJ. This provider's primary affiliated billing organization is CLINICAL HEALTH CARE ASSOCIATES OF NEW JERSEY PC (NPI: 1124122387; TIN: 232865181) and primary practice location at 08360-5843. Quinlan is affiliated with the Penn Medicine Healthcare Partners, LLC (ACO ID: A5318), participating under the MSSP model.

Quinlan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,314 traditional Medicare patients, billed 6,436 HCPCS/CPT codes, and received $340,559 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 10,895 prescription claims across 1,248 beneficiaries totaling $1,689,954 in drug costs, led by Eliquis (Apixaban). 2020 DME data shows 46 claims. Open Payments data shows 5 records totaling $111. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $324,166 to $1,689,954. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $15,047 and ending at $10,146.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,769	7,010	$441,689
2016	1,930	7,242	$433,835
2017	1,943	7,106	$428,679
2018	2,068	7,580	$466,979
2019	1,814	6,432	$386,115
2020	1,376	5,051	$343,369
2021	1,320	5,516	$372,549
2022	1,260	5,313	$356,417
2023	1,307	5,354	$336,436
2024	1,314	6,436	$340,559

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	501	3,747	$324,166
2016	585	4,711	$455,514
2017	671	5,039	$510,902
2018	768	6,041	$606,077
2019	805	6,364	$784,296
2020	850	7,417	$965,024
2021	968	8,018	$1,146,244
2022	1,069	9,221	$1,397,948
2023	1,167	9,839	$1,548,847
2024	1,248	10,895	$1,689,954

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	78	$5,252
2016	N/R	72	$2,459
2017	N/R	41	$1,342
2018	N/R	36	$1,058
2019	N/R	24	$741
2020	N/R	46	$1,732
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	392	397	$112
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	754	1,165	$90
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	683	1,029	$13
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	801	1,371	$11
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	407	477	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	602	37,320	$705,952
Xarelto	Rivaroxaban	202	15,316	$272,582
Entresto	Sacubitril/Valsartan	113	7,206	$154,293
Repatha Sureclick	Evolocumab	153	7,574	$144,057
Praluent Pen	Alirocumab	77	3,046	$50,746

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$111	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jack Francis Quinlan, M.D.?

Tedicare shows public-source Medicare data for Jack Francis Quinlan, M.D. (NPI 1942460514), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jack Francis Quinlan, M.D. have ACO affiliation data?

Jack Francis Quinlan, M.D. is shown with ACO affiliation data for Penn Medicine Healthcare Partners, LLC (MSSP, ACO ID A5318).

What billing organization is linked to Jack Francis Quinlan, M.D.?

Jack Francis Quinlan, M.D. is linked to CLINICAL HEALTH CARE ASSOCIATES OF NEW JERSEY PC (billing NPI 1124122387) in the available physician profile data.

Does Jack Francis Quinlan, M.D. have Open Payments data?

Jack Francis Quinlan, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.